Gastroenterology — API & Bulk Drug Suppliers in India

proton pump inhibitor — capsule and pellet formulations for acid-peptic disorders.

5-HT3 antagonist antiemetic — tablet, syrup and injection formulations for chemotherapy and post-operative nausea.

gastric lipase inhibitor — capsule formulations for weight management.

non-absorbed oral antibiotic — tablet formulations for hepatic encephalopathy and IBS-D.

peripheral dopamine-antagonist prokinetic — tablet and suspension formulations for nausea and gastroparesis.

S-isomer proton-pump inhibitor — tablet and capsule formulations for reflux disease and peptic ulcer.

H2-receptor antagonist — tablet and injection formulations for gastric acid suppression.

prokinetic dopamine antagonist — tablet formulations for functional dyspepsia.

proton-pump inhibitor — capsule formulations for acid-related disorders.

5-aminosalicylic acid — tablet and enema formulations for ulcerative colitis.

5-HT4-agonist prokinetic — tablet formulations for dyspepsia and gastroparesis.

proton-pump inhibitor — tablet formulations for reflux and ulcer disease, often with domperidone.

H2-receptor antagonist — tablet and injection formulations for acid-related disorders.

hydrophilic bile acid — tablet formulations for gallstones and cholestatic liver disease.

prototypical antimuscarinic alkaloid — injection formulations for bradycardia, organophosphate poisoning and pre-anaesthesia.

diphenylmethane stimulant laxative — tablet and suppository formulations for short-term constipation relief.

PDE4-inhibiting antispasmodic — tablet and injection formulations for biliary, intestinal and dysmenorrhoeic spasm.

anticholinergic antispasmodic — tablet and injection formulations for visceral spasm and motion sickness.

non-absorbed disaccharide — syrup formulations for constipation and hepatic encephalopathy.

peripheral mu-opioid agonist antidiarrhoeal — capsule formulations for acute non-infective diarrhoea.

osmotic polyethylene-glycol laxative — powder sachets, with electrolytes, for constipation and bowel preparation.

central and peripheral prokinetic — tablet and injection formulations for nausea, vomiting and gastroparesis.

farnesoid-X-receptor agonist bile acid — tablet formulations for primary biliary cholangitis.

5-HT4-agonist enterokinetic — tablet formulations for chronic constipation unresponsive to laxatives.

Proton pump inhibitor API for gastro-resistant tablets and injectables.